| Sanofi CEO meets Genzyme holders, mulls next move – Reuters |
| Posted by : admin |
Sanofi CEO meets Genzyme holders, mulls next moveReutersO) by meeting shareholders of the US biotech company face to face, the French company said Tuesday. Genzyme last week rejected an all-cash $18.5 billion …
and more »
Technorati Tags: Biotech, Biotech USA
Alligator Bioscience AB and Maxygen Inc in Settlement AgreementMarketWatchAlligator Bioscience AB, a privately owned biotech company focusing on optimization of biopharmaceuticals using its proprietary protein optimization …
Related PostsJune 16, 2010 — Alligator Bioscience AB (SE) – Alligator Bioscience AB appoints Sibylle Lenz … – PharmaLive (press release) (subscription)September 7, 2010 — Sanofi CEO meets Genzyme [...]
Comments: 0 Comments
Nanobiotix Names Laurent Condomine To Its Non-Executive BoardPrivate Equity Hub (press release)Laurent Condomine is non-executive Chairman of ExonHit, a publicly listed French biotech company. “Laurent Condomine will bring a true value to Nanobiotix; …
and more »
Related PostsAugust 11, 2010 — Karo Bio to present clinical phase III development plan for eprotirome as a … – CisionWire [...]
Comments: 0 Comments
CORRECTED-UPDATE 1-Silence Therapeutics gets approach, shares jumpLondon South EastLONDON, Sept 6 (Reuters) – Silence Therapeutics, a British biotech company that has a research partnership with AstraZeneca, said on Monday it had received …
and more »
Related PostsSeptember 3, 2010 — Scenarios: Possible outcomes of Sanofi's bid for Genzyme – ReutersSeptember 3, 2010 — Analysis: Genzyme units attract [...]
Comments: 0 Comments
| Go-getting Kiwi scientist makes good in the UK – Stuff.co.nz |
| Posted by : admin |
Go-getting Kiwi scientist makes good in the UKStuff.co.nzL’Huillier made the move from the lab bench to commerce in 2001 when he left New Zealand to join a Dutch biotech company in Melbourne. …
Related PostsMay 3, 2010 — Kiwi biotech firm on hold as it waits for new funding – New Zealand HeraldApril 23, 2010 — [...]
Comments: 0 Comments
| Scenarios: Possible outcomes of Sanofi's bid for Genzyme – Reuters |
| Posted by : admin |
Scenarios: Possible outcomes of Sanofi’s bid for GenzymeReutersPARIS (Reuters) – US biotech company Genzyme (GENZ.O) rejected an all-cash $18.5 billion offer from French drugmaker …
and more »
Technorati Tags: Biotech, Biotech USA
Comments: 0 Comments
Analysis: Genzyme units attract interest, what about Sanofi?Reuters UK… Viehbacher said this week after going public with an $18.5 billion, or $69 per share, offer for Genzyme that the US biotech company promptly rejected. …
and more »
Related PostsSeptember 3, 2010 — Scenarios: Possible outcomes of Sanofi's bid for Genzyme – ReutersSeptember 1, 2010 — Analysis: Genzyme [...]
Comments: 0 Comments
Analysis: Genzyme units attract interest but what about Sanofi?Reuters… Viehbacher said this week after going public with an $18.5 billion, or $69 per share, offer for Genzyme that the US biotech company promptly rejected. …
and more »
Technorati Tags: Biotech, Biotech USA
Comments: 0 Comments
| Board Members Differ on Genzyme Bid – Wall Street Journal |
| Posted by : admin |
Board Members Differ on Genzyme BidWall Street JournalAssociated Press Sanofi CEO Chris Viehbacher, pictured in May 2009, is pursuing a deal to acquire biotech company Genzyme. But Sanofi’s move has also …
and more »
Related PostsSeptember 7, 2010 — Sanofi CEO meets Genzyme holders, mulls next move – ReutersSeptember 3, 2010 — Scenarios: Possible outcomes of Sanofi's [...]
Comments: 0 Comments
| Jatropha: A new form of energy – TODAYonline |
| Posted by : admin |
Jatropha: A new form of energyTODAYonlineLast month, it signed a contract with Indian plant biotech company KF Bioplants (KFB). Under the contract, KFB will produce and deliver one million …
Related PostsSeptember 7, 2010 — Sanofi CEO meets Genzyme holders, mulls next move – ReutersSeptember 7, 2010 — Alligator Bioscience AB and Maxygen Inc in Settlement [...]
Comments: 0 Comments
Comments: 0 Comments